LEADER 03520nam  2200577 a 450 
001 9910813140803321
005 20200520144314.0
010   $a1-280-84159-1
010   $a9786610841592
010   $a92-4-068203-1
035   $a(CKB)1000000000334672
035   $a(OCoLC)127109981
035   $a(CaPaEBR)ebrary10161463
035   $a(SSID)ssj0000226855
035   $a(PQKBManifestationID)11198308
035   $a(PQKBTitleCode)TC0000226855
035   $a(PQKBWorkID)10260246
035   $a(PQKB)10166777
035   $a(MiAaPQ)EBC286847
035   $a(Au-PeEL)EBL286847
035   $a(CaPaEBR)ebr10161463
035   $a(CaONFJC)MIL84159
035   $a(OCoLC)437176643
035   $a(EXLCZ)991000000000334672
100   $a20080903d2006      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPreventive chemotherapy in human helminthiasis $ecoordinated use of anthelminthic drugs in control interventions : a manual for health professionals and programme managers
205   $a1st ed.
210   $aGeneva, Switzerland $cWorld Health Organization$d2006
215   $a1 online resource (74 pages)
300   $a"A first draft of this manual was prepared by the World Health Organization (WHO) in consultation with Professor D.W.T. Crompton..."--Preface.
311 0 $a92-4-154710-3 
327   $aIntro -- Title -- Contents -- Acknowledgements -- Abbreviations -- Preface -- Glossary -- Preventive chemotherapy in human helminthiasis -- Annexes -- Dosepole.
330   $aThis manual is intended to guide the coordinated implementation of regular, systematic, large-scale interventions that provide anthelminthic drug treatment as a core component of the joint and synergic control of helminthic diseases such as lymphatic filariasis, onchocerciasis, schistosomiasis and soil-transmitted helminthiasis. The manual focuses mainly on antihelminthic treatment, but other drugs used to eliminate other agents can be potentially associated to those mentioned in the manual; as a reference trachoma control through the SAFE strategy, combining drug treatment with hygiene and environmental management, can be associated to helminth control interventions to boost the overall health of affected communities. The greatest challenge is to extend regular anthelminthic drug coverage as a public health intervention to reach all individuals at risk of the morbidity caused by helminthic infections. Preventive chemotherapy should therefore begin early in life, and every opportunity should be taken to reach at-risk populations. This manual advocates much greater coordination among disease control interventions . Because such large numbers of people are affected, and are often difficult to reach, it also stresses the need to make the best use of all existing drug distribution channels to deliver anthelminthic drugs, and aims at encouraging programme managers to find other innovative means of reaching those in need in a sustainable manner.
606   $aHelminthiasis$xPrevention
606   $aHelminthiasis$xTreatment
615  0$aHelminthiasis$xPrevention.
615  0$aHelminthiasis$xTreatment.
676   $a616.962;616.962061
712 02$aWorld Health Organization.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910813140803321
996   $aPreventive chemotherapy in human helminthiasis$94039351
997   $aUNINA